Join date: Jan 11, 2022
0 Like Received
0 Comment Received
0 Best Answer
Jul 27, 2022 ∙ 1 min
Axiom Mid-Year Data Review 2022
In this report, Axiom provides a review on pivotal and paradigm shifting data from the first half of 2022 and offers our perspective on...
Jul 27, 2022 ∙ 4 min
Insights on Cell Therapy From IO360
Executive Summary IO360 underscored the importance of the starting cell type, as the overall consensus of the superior cell type was the...